74.25
Henry Schein Inc stock is traded at $74.25, with a volume of 897.72K.
It is up +0.31% in the last 24 hours and down -9.35% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
See More
Previous Close:
$74.02
Open:
$74.68
24h Volume:
897.72K
Relative Volume:
0.67
Market Cap:
$8.52B
Revenue:
$13.18B
Net Income/Loss:
$419.00M
P/E Ratio:
22.70
EPS:
3.2704
Net Cash Flow:
$521.00M
1W Performance:
+1.55%
1M Performance:
-9.35%
6M Performance:
+13.12%
1Y Performance:
+7.02%
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HSIC
Henry Schein Inc
|
74.25 | 8.49B | 13.18B | 419.00M | 521.00M | 3.2704 |
|
MCK
Mckesson Corporation
|
879.75 | 108.03B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
325.08 | 63.66B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
CAH
Cardinal Health Inc
|
211.31 | 48.76B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
AHG
Akso Health Group Adr
|
2.3693 | 1.94B | 14.85M | -136.07M | 7.23M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-23-26 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Aug-26-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-25-25 | Downgrade | Stifel | Buy → Hold |
| Jul-14-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
How Surging Global Specialty Sales At Henry Schein (HSIC) Have Changed Its Investment Story - Yahoo Finance
Henry Schein, Inc. $HSIC Shares Purchased by SG Americas Securities LLC - MarketBeat
Henry Schein stock faces uncertain trading amid lack of fresh catalysts in dental distribution secto - AD HOC NEWS
Henry Schein, Vir Biotechnology, Ultra Clean Holdings and other big stocks moving higher on Tuesday - MSN
Is Henry Schein Stock Underperforming the S&P 500? - Barchart.com
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
This Henry Schein analyst turns bullish; here are top 3 upgrades for Monday - MSN
Push Button Handpiece Conversion Midwest 380420 Low Speed AdapterHenry Schein Dental Push Button Starter Kit - hotelier.com.py
Tudor Investment Corp ET AL Invests $15.38 Million in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein Q4 2025 earnings preview - MSN
Decliners Report: Will Henry Schein Inc face regulatory challengesWeekly Market Summary & Growth Oriented Trading Recommendations - baoquankhu1.vn
Barclays Sticks to Their Buy Rating for Henry Schein (HSIC) - The Globe and Mail
Top Henry Schein Executive Makes Notable Insider Stock Move - TipRanks
Henry Schein (NASDAQ:HSIC) CEO Thomas Popeck Sells 1,355 Shares - MarketBeat
Insider Sell: Thomas Popeck Sells Shares of Henry Schein Inc (HS - GuruFocus
Charisma 66000085 Universal CompositeHenry Schein Dental - hotelier.com.py
Henry Schein CEO Popeck sells $98,630 in stock - Investing.com
Henry Schein CEO Popeck sells $98,630 in stock By Investing.com - Investing.com Australia
Henry Schein (HSIC) products CEO sells 1,355 shares in open-market trade - Stock Titan
3M Scotchbond 7423 Etchant Etching GelHenry Schein Dental - hotelier.com.py
Here's why Henry Schein (HSIC) is a strong growth stock - MSN
HSIC (NASDAQ) Form 144: insiders list 144, 191, 1,020 shares tied to vesting - Stock Titan
Zacks Research Has Negative View of Henry Schein Q1 Earnings - MarketBeat
Here's why Henry Schein (HSIC) is a strong value stock - MSN
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Henry Schein secures Ethisphere World Most Ethical Companies recognition for 15th consecutive year - Traders Union
Henry Schein Named Among World’s Most Ethical Companies - Dentistry Today
Here's Why Henry Schein (HSIC) is a Strong Growth Stock - Yahoo Finance
These analysts increase their forecasts on Henry Schein after upbeat Q4 results - MSN
NY-HENRY-SCHEIN-INC - Caledonian Record
Ethisphere Names Henry Schein as One of the 2026 World's Most Ethical Companies® for 15th Consecutive Year - Bluefield Daily Telegraph
HSIC SEC FilingsHenry Schein, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
HSIC Stock Price, Quote & Chart | HENRY SCHEIN INC (NASDAQ:HSIC) - ChartMill
HS2.DE Henry Schein (XETRA) €74.06 pre-market 18 Mar 2026: oversold bounce setup vs 50-day avg - Meyka
Henry Schein (NASDAQ: HSIC) CFO surrenders shares to cover tax withholding - Stock Titan
Henry Schein (HSIC) SVP surrenders 463 shares to cover tax withholding - Stock Titan
Henry Schein (HSIC) executive surrenders 587 shares to cover tax withholding - Stock Titan
Henry Schein (HSIC) EVP surrenders 5,928 shares to cover tax withholding - Stock Titan
[Form 4] HENRY SCHEIN INC Insider Tradi... - Stock Titan
Henry Schein (HSIC) director logs share gift and tax-related surrender - Stock Titan
Henry Schein (HSIC) exec surrenders 1,401 shares for tax withholding - Stock Titan
Henry Schein, Inc. (NASDAQ:HSIC) Short Interest Down 12.8% in February - MarketBeat
Reflecting On Dental Equipment & Technology Stocks’ Q4 Earnings: Henry Schein (NASDAQ:HSIC) - Yahoo Finance
Henry Schein Inc. stock underperforms Monday when compared to competitors - MarketWatch
Henry Schein (HSIC) director Bergman reports bona fide gift of 970 shares - Stock Titan
Kettle Hill Capital Management LLC Acquires New Holdings in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein, Inc. $HSIC is Clifford Capital Partners LLC's 2nd Largest Position - MarketBeat
Henry Schein, Inc. $HSIC is Ananym Capital Management LP's 3rd Largest Position - MarketBeat
Zuckerman Investment Group LLC Acquires 72,040 Shares of Henry Schein, Inc. $HSIC - MarketBeat
iSAM Funds UK Ltd Acquires New Stake in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein, Inc. $HSIC Shares Sold by P2 Capital Partners LLC - MarketBeat
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):